Bonuit SPC
1 Name of the medicinal product
Bonuit® Sleep Aid tablets
2 Qualitative and quantitative composition
Each coated tablet contains:
125 mg of extract (as dry extract) from Valerian root (Valeriana officinalis L.) (3-6:1) (equivalent to 375 – 750 mg of Valerian root).
Extraction solvent: Ethanol 70% v/v,
and
250mg of extract (as dry extract) from Passion flower herb (Passiflora incarnata L.) (5-7:1) (equivalent to 1250 – 1750 mg of Passion flower herb).
Extraction solvent: Ethanol 50% v/v
Excipients: each coated tablet contains 187 mg of sucrose and 32 mg of glucose.
For full list of excipients, see section 6.1
3 Pharmaceutical form
Coated tablet. Light-yellow, round, biconvex, smooth glossy surface.
4 Clinical particulars
4.1 Therapeutic indications
A traditional herbal medicinal product used for the temporary relief of sleep disturbances due to symptoms of mild anxiety, based on traditional use only.
4.2 Posology and method of administration
For oral short term use only.
For adults and the elderly, take one to two tablets half an hour before bedtime. Tablets should be swallowed whole with some water or other liquid. The tablets should not be chewed.
As treatment effects may not be apparent immediately, Bonuit should be taken for 2-4 weeks continuously.
If symptoms worsen or do not improve after 4 weeks a doctor or qualified healthcare practitioner should be consulted.
Not for children or adolescents under 18 years.
4.3 Contraindications
Hypersensitivity to Valerian, Passion Flower or any of the excipients in the product.
The product should not be used in children or adolescents under 18 years of age.
4.4 Special warnings and precautions for use
Do not exceed the stated dose.
This product contains sucrose and glucose.
1 sugar-coated tablet contains max. 187 mg of sucrose and a max. 32 mg glucose.
Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine
4.5 Interaction with other medicinal products and other forms of interaction
Only limited data on pharmacological interactions with other medicinal products are available. Additive effects with hypnotics and other sedative drugs cannot be excluded and therefore co-medication is not recommended as a general precaution.
The effect of Bonuit may be potentiated by alcohol. Excessive concomitant consumption of alcohol should therefore be avoided.
4.6 Fertility, pregnancy and lactation
The safety of the product during pregnancy and lactation has not been established. Therefore it should be avoided during pregnancy or lactation.
Studies on fertility have not been performed.
4.7 Effects on ability to drive and use machines
May impair the ability to drive and use machines. If affected, do not drive or operate machines.
4.8 Undesirable effects
Gastrointestinal symptoms, such as nausea, abdominal cramps, may occur. The frequency is not known. One case of hypersensitivity (vasculitis) and one case of tachycardia have been reported with Passion Flower. The frequency is not known.
If other adverse reactions not mentioned above occur, a doctor or qualified healthcare practitioner should be consulted.
4.9 Overdose
Valerian root at a dose of approximately 20 g (equivalent to 10 tablets) caused benign symptoms (fatigue, abdominal cramp, chest tightness, lightheadedness, hand tremor and mydriasis), which disappeared within 24 hours. If symptoms arise, treatment should be supportive.
After intake of very high doses of Valerian root over several years (daily consumption corresponding to approximately 30 g of the drug) withdrawal symptoms (delirium) have been reported.
No cases of overdose have been reported for Passion Flower.
5 Pharmacological properties
5.1 Pharmacodynamic properties
Not required as per Article 16c(1)(a)(iii) of Directive 2001/83/EC as amended.
5.2 Pharmacokinetic properties
Not required as per Article 16c(1)(a)(iii) of Directive 2001/83/EC as amended.
5.3 Preclinical safety data
The preclinical toxicology data available are limited. Tests on reproductive toxicity, genotoxicity and carcinogenicity have not been performed.
6 Pharmaceutical particulars
6.1 List of excipients
Tablet Core
- Maltodextrin
- Silica, colloidal anhydrous
- Cellulose, powdered
- Croscarmellose sodium
- Magnesium stearate
- Stearic acid
- Talc
- Liquid glucose, spray dried
Coating
- Sucrose
- Talc
- Calcium carbonate E170
- Acacia
- Tragacanth
- Titanium dioxide E 171
- Liquid glucose, spray dried
- Iron oxide hydrate E 172 (=yellow iron oxide)
- Hypromellose
- Capol 600 T.S. containing:
- Beeswax, white
- Carnauba wax
- Shellac
6.2 Incompatibilities
Not applicable.
6.3 Shelf life
The shelf life is 4 years
6.4 Special precautions for storage
Do not store above 30°C.
6.5 Nature and contents of container
Original packages contain 14, 15, 28 and 30 coated tablets
Bonuit® Sleep Aid tablets are packed in PVC/VDC- aluminium blisters and inserted into a carton.
6.6 Special precautions for disposal
No special requirements
7 Registration holder
Schwabe Pharma (UK) Ltd
Alexander House
Mere Park
Dedmere Road
Marlow
Buckinghamshire
SL7 1FX
8 Registration number
THR 23056/0006
9 Date of first registration authorisation
3rd March 2008